Bonus Biogroup Correlations

BONS Stock  ILS 10.80  0.10  0.93%   
The current 90-days correlation between Bonus Biogroup and Bezeq Israeli Telecommunication is 0.13 (i.e., Average diversification). The correlation of Bonus Biogroup is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Bonus Biogroup Correlation With Market

Modest diversification

The correlation between Bonus Biogroup and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Bonus Biogroup and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Bonus Biogroup could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bonus Biogroup when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bonus Biogroup - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bonus Biogroup to buy it.

Moving together with Bonus Stock

  0.62ICB Israel China BiotechPairCorr
  0.82BIGT Big Tech 50PairCorr
  0.83PLAZ-L Plaza Centers NVPairCorr

Moving against Bonus Stock

  0.84GOLD Gold BondPairCorr
  0.8INBR Inbar Group FinancePairCorr
  0.69OVRS Overseas CommercePairCorr
  0.6CLBV Clal IndustriesPairCorr
  0.35NXTG Nextage TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Bonus Stock performing well and Bonus Biogroup Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bonus Biogroup's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bonus Biogroup without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module